Gunnar Esiason

Bio:

Gunnar Esiason is Vice President, Patient Strategy and Innovation at Raven, RA Capital's healthcare incubator. Gunnar is a cystic fibrosis patient and an accomplished patient advocate who is passionate about early-stage drug development, patient empowerment, and health policy. Prior to joining RA Capital, Gunnar worked at both venture firms and startup companies, focusing on new company creation, early-stage growth, and patient adoption of novel healthcare technologies. He has also been the face of fundraising for the Boomer Esiason Foundation, which has raised close to $200 million in the fight against cystic fibrosis. He was a founding member of No Patient Left Behind, where he still serves on the board today, and has advised on patient engagement tactics at companies ranging from small startups to large multinationals in the life science space. Gunnar holds an M.B.A. from the Tuck School of Business at Dartmouth, where he was a Wilson Scholar and received the Julia Stell Award, an M.P.H. from the Dartmouth Institute for Health Policy & Clinical Practice, and a B.A. from Boston College. His health policy opinions have been featured in the Wall Street Journal, USA Today, The Hill, and STAT News.